NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/07/2025
Back to search
Official data from USPTO
SYLVAN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYLVAN THERAPEUTICS
ST13
US500000085867398Class
5
Filing
85867398
Registration
4735760
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
09/08/2025
Trademark type
Word
Nice classes
5
Filing date
03/05/2013
Registration date
05/12/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/07/2025
Last transaction
09/08/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/31/2013
First use in commerce
03/31/2013
Drawing code
4
Owner type
03
Owner location
Kittanning, PA
Examiner
MCPHERSON RAYBURN, SHAVELL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sylvan Bio Inc.
Sylvan Bio Inc.
Representatives
Joshua W. Newman REED SMITH LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
38 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/07/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/07/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
05/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/12/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/13/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/13/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/13/2021
E815
TEAS SECTION 8 & 15 RECEIVED
03/03/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/07/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/06/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/16/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2014
EX1G
SOU EXTENSION 1 GRANTED
12/16/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/15/2014
EXT1
SOU EXTENSION 1 FILED
11/04/2014
EEXT
SOU TEAS EXTENSION RECEIVED
11/04/2014
IUAF
USE AMENDMENT FILED
10/15/2014
EISU
TEAS STATEMENT OF USE RECEIVED
10/15/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/06/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2014
PUBO
PUBLISHED FOR OPPOSITION
03/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/31/2014
ALIE
ASSIGNED TO LIE
01/31/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/17/2013
GNRT
NON-FINAL ACTION E-MAILED
06/17/2013
CNRT
NON-FINAL ACTION WRITTEN
06/17/2013
DOCK
ASSIGNED TO EXAMINER
06/16/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2013
NWAP
NEW APPLICATION ENTERED
03/08/2013
Continuous trademark protection
Get notified about every new filing that threatens SYLVAN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.